BOD member resignation announced in the AH. Could be the 'second clue' that TKAI is making room for the introduction of a new entity!
Additional resignations would be affirming.
(b) On October 10, 2016, Timothy J. Barberich notified Tokai Pharmaceuticals, Inc. (the “Company”) of his resignation as a member of the board of directors of the Company and the compensation, audit and nominating and corporate governance committees thereof, effective immediately. Mr. Barberich’s decision to resign did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
